Penumbra (PEN) Stock Research

Over a week ago

Penumbra reports Q2 EPS 88c, consensus $1.18

Jul 30, 4:13 PM

Penumbra says THUNDER study met predefined performance goal

Jul 22, 2:41 PM

Penumbra announces the initiation of its FORWARD study

Jul 7, 9:04 AM

Penumbra price target lowered by $15 at Evercore ISI, here's why

Jul 6, 8:46 AM

Penumbra secured CE Mark in Europe for Thunderbolt

Jun 15, 9:01 AM

Penumbra receives FDA clearance for Thunderbolt

Jun 11, 4:07 PM

Soros buys Penumbra, exits Take-Two in Q1

+18

May 15, 4:53 PM

Penumbra price target lowered by $10 at Evercore ISI

May 7, 8:06 AM

Penumbra price target lowered by $24 at Citi

May 7, 6:36 AM

Penumbra reports Q1 EPS 82c, consensus $1.06

May 6, 4:15 PM

Penumbra announces 90-day results of STORM-PE randomized controlled trial

Apr 13, 9:04 AM

Penumbra price target lowered by $15 at Evercore ISI, here's why

Apr 6, 8:10 AM

FTC issued Second Request to Penumbra, Boston Scientific over merger review

Mar 30, 12:53 PM

Private Markets: Kraken pauses IPO plans, Quince raises $500M

+26

Mar 19, 1:15 PM

Penumbra price target raised by $20 at Evercore ISI, here's why

Feb 25, 2:48 PM

Penumbra trading resumes

Feb 25, 1:17 PM

Penumbra reports Q4 adjusted EPS $1.18, consensus $1.11

Feb 25, 1:02 PM

Penumbra trading halted, news pending

Feb 25, 12:57 PM

Penumbra just downgraded at RBC Capital, here's why

Jan 20, 6:34 AM

Penumbra just downgraded at Canaccord, here's why

Jan 20, 5:06 AM

Penumbra just downgraded at Needham, here's why

Jan 16, 8:58 AM

Penumbra downgraded to Hold from Buy at Jefferies

Jan 16, 8:55 AM

Boston Scientific price target lowered by $25 at Oppenheimer, here's why

Jan 16, 7:46 AM

Penumbra just downgraded at Baird, here's why

Jan 16, 5:12 AM

Penumbra just downgraded at Truist, here's why

Jan 16, 5:01 AM

Over a week ago

Penumbra reports Q2 EPS 88c, consensus $1.18

Jul 30, 4:13 PM

Penumbra says THUNDER study met predefined performance goal

Jul 22, 2:41 PM

Penumbra announces the initiation of its FORWARD study

Jul 7, 9:04 AM

Penumbra price target lowered by $15 at Evercore ISI, here's why

Jul 6, 8:46 AM

Penumbra secured CE Mark in Europe for Thunderbolt

Jun 15, 9:01 AM

Penumbra receives FDA clearance for Thunderbolt

Jun 11, 4:07 PM

Soros buys Penumbra, exits Take-Two in Q1

+18

May 15, 4:53 PM

Penumbra price target lowered by $10 at Evercore ISI

May 7, 8:06 AM

Penumbra price target lowered by $24 at Citi

May 7, 6:36 AM

Penumbra reports Q1 EPS 82c, consensus $1.06

May 6, 4:15 PM

Penumbra announces 90-day results of STORM-PE randomized controlled trial

Apr 13, 9:04 AM

Penumbra price target lowered by $15 at Evercore ISI, here's why

Apr 6, 8:10 AM

FTC issued Second Request to Penumbra, Boston Scientific over merger review

Mar 30, 12:53 PM

Private Markets: Kraken pauses IPO plans, Quince raises $500M

+26

Mar 19, 1:15 PM

Penumbra price target raised by $20 at Evercore ISI, here's why

Feb 25, 2:48 PM

Penumbra trading resumes

Feb 25, 1:17 PM

Penumbra reports Q4 adjusted EPS $1.18, consensus $1.11

Feb 25, 1:02 PM

Penumbra trading halted, news pending

Feb 25, 12:57 PM

Penumbra just downgraded at RBC Capital, here's why

Jan 20, 6:34 AM

Penumbra just downgraded at Canaccord, here's why

Jan 20, 5:06 AM

Penumbra just downgraded at Needham, here's why

Jan 16, 8:58 AM

Penumbra downgraded to Hold from Buy at Jefferies

Jan 16, 8:55 AM

Boston Scientific price target lowered by $25 at Oppenheimer, here's why

Jan 16, 7:46 AM

Penumbra just downgraded at Baird, here's why

Jan 16, 5:12 AM

Penumbra just downgraded at Truist, here's why

Jan 16, 5:01 AM

Company News

Charts